Resistance to Immunotherapeutic Antibodies in Cancer

Strategies to Overcome Resistance

Editors:

ISBN: 978-1-4614-7653-5 (Print) 978-1-4614-7654-2 (Online)

Table of contents (10 chapters)

  1. Front Matter

    Pages i-xiii

  2. No Access

    Book Chapter

    Pages 1-24

    Resistance to Anticancer Antibodies: From Mechanisms to Solutions

  3. No Access

    Book Chapter

    Pages 25-47

    Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence

  4. No Access

    Book Chapter

    Pages 49-71

    Overcoming Resistance to Therapeutic Antibodies by Targeting Fc Receptors

  5. No Access

    Book Chapter

    Pages 73-92

    Understanding the Mechanisms of Resistance to Rituximab: Paving the Road for the Development of Therapeutic Strategies to Overcome Rituximab-Resistance

  6. No Access

    Book Chapter

    Pages 93-124

    Tumor Resistance to Antibody-Mediated Immunotherapy and Reversal of Resistance: Rituximab as Prototype

  7. No Access

    Book Chapter

    Pages 125-141

    Resistance to the Anti-EGFR Therapy, Beyond KRAS, in Patients with Metastatic Colorectal Cancer

  8. No Access

    Book Chapter

    Pages 143-155

    Overcoming Resistance of Melanoma to Immunotherapy with Monoclonal Antibodies Against Checkpoints Inhibitors

  9. No Access

    Book Chapter

    Pages 157-166

    Strategies to Overcome TRAIL Resistance in Cancer

  10. No Access

    Book Chapter

    Pages 167-181

    Unnatural Amino Acid Antibody Conjugates as Next Generation Biologics

  11. No Access

    Book Chapter

    Pages 183-200

    Antibody-Drug Conjugates: Can Coupling Cytotoxicity and Specificity Overcome Therapeutic Resistance?

  12. Back Matter

    Pages 201-202